EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting SHP1 and SHP2 to suppress tumors and enhance immunosurveillance

Yijun Zhao, Linjia Jiang

Trends in Cell Biology · 2025-08 · 35 (8) · 667-677

DOI: 10.1016/j.tcb.2024.10.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cell Biology, 2025-08. Verfasst von Yijun Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Zhongshan School of Medicine, …. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Protein Tyrosine Phosphatase, Non-Receptor Type 6, Neoplasms, Immunologic Surveillance. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Guangdong Innovative and Entrepreneurial Research Team Program, Basic and Applied Basic Research Foundation of Guangdong Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nonreceptor tyrosine phosphatases (PTPS) SHP1 and SHP2 have crucial roles in dephosphorylating an array of substrates involved in pathways comprising receptor tyrosine kinases (RTKs) and immune receptors. This regulation maintains a delicate balance between the activation and inhibition of signal transduction, ensuring appropriate biological outcomes. In this review, we summarize research focused on elucidating the functions of SHP1 and SHP2 in hematopoiesis, immune regulation, and tumor biology, emphasizing recent findings related to cancer-driven immune evasion. Furthermore, we highlight the significant effects of SHP1 and SHP2 inhibitors in enhancing cancer treatment, specifically through the facilitation of chemotherapy and augmentation of immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine Phosphatase, Non-Receptor Type 6NeoplasmsImmunologic SurveillanceHumansAnimalsSignal TransductionMolecular Targeted Therapy

Stichwörter der Autor:innen

SHP1SHP2chemoresistanceimmune checkpointimmunosurveillancereceptor tyrosine kinasesignal transductiontumorigenesis

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine Phosphatase, Non-Receptor Type 6

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510000, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510000, China. Electronic…

Förderung

  • Guangdong Innovative and Entrepreneurial Research Team Program
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, Y., & Jiang, L. (2025). Targeting SHP1 and SHP2 to suppress tumors and enhance immunosurveillance. Trends in Cell Biology, 35(8), 667-677. https://doi.org/10.1016/j.tcb.2024.10.008

Vancouver

Zhao Y, Jiang L. Targeting SHP1 and SHP2 to suppress tumors and enhance immunosurveillance. Trends in Cell Biology. 2025;35(8):667-677. doi:10.1016/j.tcb.2024.10.008

BibTeX
@article{Zhao2025,
  author = {Zhao, Yijun and Jiang, Linjia},
  title = {Targeting SHP1 and SHP2 to suppress tumors and enhance immunosurveillance},
  journal = {Trends in Cell Biology},
  year = {2025},
  volume = {35},
  number = {8},
  pages = {667--677},
  doi = {10.1016/j.tcb.2024.10.008}
}
Kostenlos starten →